Conjugates of neodegradants.

CL202601623A1Pending Publication Date: 2026-07-10BRISTOL MYERS SQUIBB CO +1

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: CL202601623
Authority / Receiving Office: CL · CL
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2022-06-02
Filing Date: 2026-05-18
Publication Date: 2026-07-10

Application Information

Patent Timeline

02 Jun 2022

Priority

18 May 2026

Application

CL202601623

10 Jul 2026

Publication

CL202601623A1

IPC: A61K45/06; A61K31/454; A61K47/68; A61P35/00; C07H15/203; C07H19/23

CPC: A61K47/6803; A61K31/454; A61P35/00; A61K47/6849; A61K47/6867; A61K45/06; C07H15/203; A61K47/6889

Inventors: FISHKIN Nathan; PARK Peter U

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present invention provides a neodegrading antibody optionally conjugated with binding fractions, wherein said anti-CD33 antibody is structurally defined by its regions determining the complementarity of the heavy and light chain variable region.

Need to check novelty before this filing date? Find Prior Art